
Carmine Cuda
Examiner (ID: 8210)
| Most Active Art Unit | 3205 |
| Art Unit(s) | 3201, 3205, 2878 |
| Total Applications | 602 |
| Issued Applications | 542 |
| Pending Applications | 0 |
| Abandoned Applications | 60 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6745176
[patent_doc_number] => 20030022359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Transgenic algae for delivering antigens to an animal'
[patent_app_type] => new
[patent_app_number] => 09/885392
[patent_app_country] => US
[patent_app_date] => 2001-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10220
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022359.pdf
[firstpage_image] =>[orig_patent_app_number] => 09885392
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/885392 | Transgenic algae for delivering antigens to an animal | Jun 19, 2001 | Abandoned |
Array
(
[id] => 816830
[patent_doc_number] => 07410637
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-12
[patent_title] => 'Transgenic algae for delivering antigens to an animal'
[patent_app_type] => utility
[patent_app_number] => 10/311741
[patent_app_country] => US
[patent_app_date] => 2001-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 10577
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/410/07410637.pdf
[firstpage_image] =>[orig_patent_app_number] => 10311741
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/311741 | Transgenic algae for delivering antigens to an animal | Jun 19, 2001 | Issued |
Array
(
[id] => 5861531
[patent_doc_number] => 20020124274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Delivery system'
[patent_app_type] => new
[patent_app_number] => 09/882302
[patent_app_country] => US
[patent_app_date] => 2001-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8835
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20020124274.pdf
[firstpage_image] =>[orig_patent_app_number] => 09882302
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/882302 | Delivery system | Jun 17, 2001 | Abandoned |
Array
(
[id] => 6954165
[patent_doc_number] => 20050229260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Compound screens relating to insulin deficiency or insulin resistance'
[patent_app_type] => utility
[patent_app_number] => 10/297336
[patent_app_country] => US
[patent_app_date] => 2001-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 74
[patent_figures_cnt] => 74
[patent_no_of_words] => 17084
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10297336
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/297336 | Compound screens relating to insulin deficiency or insulin resistance | Jun 7, 2001 | Abandoned |
Array
(
[id] => 6775645
[patent_doc_number] => 20030018984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'IGF-I expression system and methods of use'
[patent_app_type] => new
[patent_app_number] => 09/861101
[patent_app_country] => US
[patent_app_date] => 2001-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 25801
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20030018984.pdf
[firstpage_image] =>[orig_patent_app_number] => 09861101
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/861101 | IGF-I expression system and methods of use | May 17, 2001 | Abandoned |
| 09/856052 | Nucleic acid transporter and medicinal compositions for gene therapy | May 16, 2001 | Abandoned |
Array
(
[id] => 6921766
[patent_doc_number] => 20010029251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-11
[patent_title] => 'Methods and compositions for preventing or retarding the development of a atherosclerotic lesions'
[patent_app_type] => new
[patent_app_number] => 09/859242
[patent_app_country] => US
[patent_app_date] => 2001-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9429
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20010029251.pdf
[firstpage_image] =>[orig_patent_app_number] => 09859242
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/859242 | Methods and compositions for preventing or retarding the development of a atherosclerotic lesions | May 16, 2001 | Abandoned |
Array
(
[id] => 6797501
[patent_doc_number] => 20030176375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Method of treating anemia'
[patent_app_type] => new
[patent_app_number] => 09/855145
[patent_app_country] => US
[patent_app_date] => 2001-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10735
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176375.pdf
[firstpage_image] =>[orig_patent_app_number] => 09855145
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/855145 | Method of treating anemia | May 13, 2001 | Abandoned |
Array
(
[id] => 6450202
[patent_doc_number] => 20020177550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-28
[patent_title] => 'Method for inhibiting tumor invasion or spreading in a subject'
[patent_app_type] => new
[patent_app_number] => 09/851071
[patent_app_country] => US
[patent_app_date] => 2001-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7082
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20020177550.pdf
[firstpage_image] =>[orig_patent_app_number] => 09851071
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/851071 | Method for inhibiting tumor invasion or spreading in a subject | May 7, 2001 | Issued |
Array
(
[id] => 813895
[patent_doc_number] => 07414169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-19
[patent_title] => 'Therapeutic and diagnostic tools for impaired glucose tolerance conditions'
[patent_app_type] => utility
[patent_app_number] => 09/844353
[patent_app_country] => US
[patent_app_date] => 2001-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 56
[patent_no_of_words] => 34571
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/414/07414169.pdf
[firstpage_image] =>[orig_patent_app_number] => 09844353
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/844353 | Therapeutic and diagnostic tools for impaired glucose tolerance conditions | Apr 26, 2001 | Issued |
Array
(
[id] => 6892265
[patent_doc_number] => 20010018427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-30
[patent_title] => 'Method of using a scavenger receptor in the treatment of atherosclerosis'
[patent_app_type] => new
[patent_app_number] => 09/836733
[patent_app_country] => US
[patent_app_date] => 2001-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11564
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20010018427.pdf
[firstpage_image] =>[orig_patent_app_number] => 09836733
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/836733 | Method of using a scavenger receptor in the treatment of atherosclerosis | Apr 16, 2001 | Abandoned |
Array
(
[id] => 6047504
[patent_doc_number] => 20020168623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Compositions and methods for induction of proteins involved in xenobiotic metabolism'
[patent_app_type] => new
[patent_app_number] => 09/832621
[patent_app_country] => US
[patent_app_date] => 2001-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 18911
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20020168623.pdf
[firstpage_image] =>[orig_patent_app_number] => 09832621
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/832621 | Compositions and methods for induction of proteins involved in xenobiotic metabolism | Apr 10, 2001 | Abandoned |
Array
(
[id] => 1400587
[patent_doc_number] => 06534311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-03-18
[patent_title] => 'Drosophila melanogaster p70S6 kinase'
[patent_app_type] => B2
[patent_app_number] => 09/817310
[patent_app_country] => US
[patent_app_date] => 2001-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15336
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/534/06534311.pdf
[firstpage_image] =>[orig_patent_app_number] => 09817310
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/817310 | Drosophila melanogaster p70S6 kinase | Mar 25, 2001 | Issued |
Array
(
[id] => 830346
[patent_doc_number] => 07399900
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-15
[patent_title] => 'Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can used in the treatment of the above disease states and identification of anematode gene'
[patent_app_type] => utility
[patent_app_number] => 10/239249
[patent_app_country] => US
[patent_app_date] => 2001-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 13760
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/399/07399900.pdf
[firstpage_image] =>[orig_patent_app_number] => 10239249
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/239249 | Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can used in the treatment of the above disease states and identification of anematode gene | Mar 20, 2001 | Issued |
Array
(
[id] => 5803707
[patent_doc_number] => 20020010946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => '21612, 21615, 21620, 21676, 33756, novel human alcohol dehydrogenases'
[patent_app_type] => new
[patent_app_number] => 09/796089
[patent_app_country] => US
[patent_app_date] => 2001-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 35044
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20020010946.pdf
[firstpage_image] =>[orig_patent_app_number] => 09796089
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/796089 | 21612, 21615, 21620, 21676, 33756, novel human alcohol dehydrogenases | Feb 27, 2001 | Abandoned |
Array
(
[id] => 6097373
[patent_doc_number] => 20020052473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-02
[patent_title] => 'Interleukin-1 homologue, mat IL-1H4'
[patent_app_type] => new
[patent_app_number] => 09/788963
[patent_app_country] => US
[patent_app_date] => 2001-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10339
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20020052473.pdf
[firstpage_image] =>[orig_patent_app_number] => 09788963
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/788963 | Interleukin-1 homologue, mat IL-1H4 | Feb 19, 2001 | Abandoned |
Array
(
[id] => 6343881
[patent_doc_number] => 20020035078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Enzyme having S-adenosyl-L-homocysteine hydrolase (AHCY) type activity'
[patent_app_type] => new
[patent_app_number] => 09/782051
[patent_app_country] => US
[patent_app_date] => 2001-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4880
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20020035078.pdf
[firstpage_image] =>[orig_patent_app_number] => 09782051
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/782051 | Enzyme having S-adenosyl-L-homocysteine hydrolase (AHCY) type activity | Feb 13, 2001 | Abandoned |
Array
(
[id] => 5803703
[patent_doc_number] => 20020010945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'Kelch family of proteins and use thereof'
[patent_app_type] => new
[patent_app_number] => 09/780258
[patent_app_country] => US
[patent_app_date] => 2001-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11984
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20020010945.pdf
[firstpage_image] =>[orig_patent_app_number] => 09780258
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/780258 | Kelch family of proteins and use thereof | Feb 8, 2001 | Abandoned |
Array
(
[id] => 6921555
[patent_doc_number] => 20010029040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-11
[patent_title] => 'Agent for gene therapy of dilated cardomyopathy'
[patent_app_type] => new
[patent_app_number] => 09/768807
[patent_app_country] => US
[patent_app_date] => 2001-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7014
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20010029040.pdf
[firstpage_image] =>[orig_patent_app_number] => 09768807
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/768807 | Agent for gene therapy of dilated cardiomyopathy | Jan 24, 2001 | Issued |
| 09/768125 | Use of prohibitin RNA in treatment of cancer | Jan 22, 2001 | Abandoned |